期刊文献+

胆固醇酯转运蛋白-629C/A基因多态性与脑梗死的关系 被引量:1

Relationship between polymorphism of cholesteryl ester transfer protein-629C/A gene and cerebral infarction
下载PDF
导出
摘要 目的:从基因角度研究脑梗死发病的影响因素。方法:选择脑梗死患者200例(对照组)和健康体检者170例(对照组),用聚合酶链反应-限制性片段长度多态性(PCR-RELP)技术检测基因型。结果:观察组CETP-629C/A位点的A等位基因频率以及突变纯合子AA基因型频率高于对照组(P<0.05),CETP-629C/A位点AC、CC组间的基因型频率,C等位基因频率两组间比较差异无统计学意义(P>0.05);AA基因型、低密度脂蛋白、胆固醇、甘油三酯为脑梗死独立危险因素(OR>1,P<0.05)。结论:CETP-629C/A基因位点AA基因型是脑梗死发病的危险因素。 Objective: To study the relationship between polymorphism of cholesteryl ester transfer protein(CETP) - 629C/A gene and cerebral infarction, Methods:A total of 200 eases of patients with cerebral infarction, and 170 cases of healthy objects checked up in physical examination received polymerase chain reaction restriction fragment length polymorphism (PCR -RELP) genotype detection technology. Results:The CETP- 629C/A site of cerebral infarction group A allele frequency and mutation homozygote AA genotype frequency was significantly higher than that of the control group ( P 〈0.05), and CETP- 629C/A ganotype AC, CC groups, and C allele frequencies between the two groups had no statistical difference ( P 〉 0.05 ). AA genotype, low - density lipoprotein, cholesterol, and triglyeerides were independent risk factors for cerebral infarction ( OR 〉 1, P 〈0.05). Conclusion:CETP -629C/A gene AA genotype was the risk factor for cerebral infarction.
出处 《包头医学院学报》 CAS 2017年第3期89-91,共3页 Journal of Baotou Medical College
关键词 脑梗死胆固醇酯转运蛋白 基因多态性 Cerebral infarction Cholesteryl ester transfer protein Gene polymorphism
  • 相关文献

参考文献2

二级参考文献23

  • 1汪俊军,顾勤花,张春妮.高脂血症人群血清胆固醇酯转运蛋白的水平[J].中国动脉硬化杂志,2006,14(12):1038-1040. 被引量:6
  • 2Wright RS. Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol. Curr Opin Cardio1,2013 ,28 :389-398.
  • 3Bochem AE, Kuivenhoven JA, Stroes ES. The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular dis- ease. Curr Pharm Des,2013,19:3143-3149.
  • 4Charles MA, Kane JP. New molecular insights into CETP structure and function: a review. J Lipid Res,2012,53:1451-1458.
  • 5Ghosh RK, Ghosh SM. Current status of CETP inhibitors in the treatment of hyperlipidemia: an update. Curt Clin Pharmacol,2012,7 : 102-110.
  • 6吴逊.全国第四届脑血管病学术会议纪要.卒中与神经疾病,1997,4:105-109.
  • 7Sharma VK, Kawnayn G, Sarkar N. Acute ischemie stroke : comparison of low-dose and standard-dose regimes of tissue plasminogen activator. Ex- pert Rev Neurother,2013,13 : 895-902.
  • 8Niesor EJ,von der Mark E,Calabresi L,et al. Lipid and apoprotein corn-position of HDL in partial or complete CETP deficiency. Curt Vase Phar- maco1,2012,10:422-431.
  • 9Salakhutdinov NF, Rogoza LN, Tolstikov GA. Hypercholesterolemia: chemical aspect of approach. Curt Med Chem ,2011,18:4076-4105.
  • 10Sofat R, Hingorani AD, Smeeth L, et al. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorohisms. Circulation,2010,121:52-62.

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部